<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02783157</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00071148</org_study_id>
    <nct_id>NCT02783157</nct_id>
  </id_info>
  <brief_title>Transcutaneous Autonomic Modulation in Thoracic Surgery</brief_title>
  <acronym>TON-POINTS</acronym>
  <official_title>Transcutaneous Autonomic Modulation to Prevent Organ Injury After Thoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators aim to determine whether non-invasive autonomic modulation
      decreases inflammation and complications after thoracic surgery. The investigators will test
      the hypothesis that low-level transcutaneous vagal nerve stimulation (LLVNS) during major
      thoracic surgery reduces inflammation and complications, particularly postoperative atrial
      fibrillation (POAF). This will be a prospective randomized pilot trial of 200 patients
      undergoing major thoracic surgery including lobectomy, bilobectomy, or pneumonectomy via
      either video-assisted thoracoscopic (VAT) or open thoracotomy. Patients will be randomized to
      receive ether a) LLVNS (n=100) or b) sham LLVNS (n=100) during their procedure. All patients
      will receive standardized anesthetic, surgical, and post-surgical care. The primary outcome
      in this study will be time to occurrence of in-hospital POAF, which will be compared between
      groups using Cox proportional hazards models. Secondary outcomes will be ICU and hospital
      length of stay, postoperative morbidity, postoperative mortality, and serologic markers of
      inflammation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence/Burden of Postoperative Atrial Fibrillation</measure>
    <time_frame>Inpatient hospitalization approximately 3 to 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative morbidity</measure>
    <time_frame>Inpatient hospitalization approximately 3 to 7 days, and one year after surgery</time_frame>
    <description>The incidence of complications during the index hospitalization and one year after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative mortality</measure>
    <time_frame>Inpatient hospitalization approximately 3 to 7 days, and one year after surgery</time_frame>
    <description>The incidence of complications during the index hospitalization and one year after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serologic Markers of Inflammation</measure>
    <time_frame>Inpatient hospitalization approximately 3 to 7 days</time_frame>
    <description>Cytokine levels, measured in pg/mL</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Atrial Fibrillation, Postoperative</condition>
  <condition>Postoperative Complications</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Transcutaneous low-level vagal nerve stimulation (LLVNS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>n=100 patients will be randomized to transcutaneous low-level vagal nerve stimulation (LLVNS), via a clip applied to the ear. Stimulation will be delivered throughout the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham LLVNS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>n=100 patients will be randomized to sham LLVNS, with the clip applied but no stimulation delivered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Low-Level Vagal Nerve Stimulation (LLVNS)</intervention_name>
    <description>Low-level vagal nerve stimulation will be delivered via a clip applied to the ear throughout the surgical procedure. The voltage used will be individualized to each patient, based upon the voltage necessary to slow the sinus rate during testing.</description>
    <arm_group_label>Transcutaneous low-level vagal nerve stimulation (LLVNS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham LLVNS</intervention_name>
    <description>A clip will be applied to the ear, but no stimulation will be delivered throughout the procedure.</description>
    <arm_group_label>Sham LLVNS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major thoracic surgery (lobectomy, bilobectomy, or pneumonectomy via either
             video-assisted thoracoscopic (VAT) or open thoracotomy)

        Exclusion Criteria:

          -  Patients &gt;90 or &lt;40 years of age

          -  Chronic atrial fibrillation

          -  Prior splenectomy

          -  Preoperative inotropic support

          -  Hepatic or renal failure

          -  Currently receiving vagal nerve stimulation therapy

          -  Taking centrally-acting cholinergic medications (tacrine, donepezil, rivastigmine)

          -  High-grade atrioventricular block (&gt;2nd degree atrioventricular blockade)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph P Mathew, MD, MHS, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathan H Waldron, MD</last_name>
    <phone>919-724-5217</phone>
    <email>nathan.waldron@dm.duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan H Waldron, MD</last_name>
      <phone>919-724-5217</phone>
      <email>nathan.waldron@dm.duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tiffany Bisanar, RN, BSN, CCRP</last_name>
      <phone>919-681-0866</phone>
      <email>tiffany.bisanar@duke.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Stavrakis S, Humphrey MB, Scherlag BJ, Hu Y, Jackman WM, Nakagawa H, Lockwood D, Lazzara R, Po SS. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J Am Coll Cardiol. 2015 Mar 10;65(9):867-75. doi: 10.1016/j.jacc.2014.12.026.</citation>
    <PMID>25744003</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2016</study_first_submitted>
  <study_first_submitted_qc>May 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2016</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autonomic</keyword>
  <keyword>Vagal nerve stimulation</keyword>
  <keyword>Postoperative atrial fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

